SUM Summerset Group

Started by winner (n), Jul 09, 2022, 02:32 PM

Previous topic - Next topic

0 Members and 0 Guests are viewing this topic.

Buzz

Quote from: Basil on Feb 17, 2026, 02:53 PMSee the thread on possible refloat of MET.  I think the overhang will put pressure on the pricing of the entire sector until its dealt with.  EQT are "brave" to try and relist MET in the prevailing environment for the sector on the NZX.   They're probably sick of the pathetic return they've got on assets employed by MET and want to give others the "opportunity" to be involved.  I see it as an attempted "hospital pass"  Who wants to be left holding the baby with shitty nappies ?

Can you provide some detail on MET's "pathetic return" since they delisted?
Age is not a good measure of ability

Basil

They still report on the NZX because the MET010 bonds are still listed. Reporting over the years is all there on the NZX under that ticker.

Minimoke

Fill year results just announced
SUMMERSET POSTS $234.2M FULL YEAR UNDERLYING PROFIT

• Underlying profit for FY25 of NZ$234.2m, up 13% on FY24
• IFRS net profit $259.7m down 22% on FY24
• Total revenue of NZ$361.8m up 13% on FY24
• Total assets of NZ$9.2b, up 15% on FY24
• 1,560 total sales of occupation rights, up 26% on FY24
• 693 new homes delivered under occupation right agreement (ORA) (637 in New Zealand and 56 in Australia)
• Land bank total of 5,499 retirement homes and 1,173 care homes across NZ and Australia
• Uncontracted NZ stock decreased 7% compared to 1H25
• Development margin of 27.8%
• Final dividend of NZ13.2 cents per share
• Village and care resident satisfaction 91% and 89% respectively
• Staff retention 84% up 3% on FY24

Dolcile

Anyone got a view on why the SP is down in the low $10's.  Down a couple of bucks in the last 2 months. 

The year end report looks good to me.

entrep

There's another thread here, but Basil mentioned that it's possibly due to funds selling down to purchase, I think, Metlife Care, possible listing. https://stocktalk.co.nz/index.php?topic=408.0
AI-powered NZX announcement analysis → annolyse.ai

Turkey

#320
Quote from: Dolcile on Feb 27, 2026, 11:21 AMAnyone got a view on why the SP is down in the low $10's.  Down a couple of bucks in the last 2 months. 

The year end report looks good to me.

I'm not aware of anything specific to SUM but maybe the subdued outlook for NZ residential property market and the sharp reversal from last years forecast of dropping OCR to rising.

I think some of the analyst might have a view they can't keep growing at the pace without increasing their debt levels which are already on the high side.
All the listed RVs are down similar amount YTD

OCA -12%
RYM -14%
SUM -14%


SUM are the NVIdia of the sector...keeps on delivering and market still chooses to mark it down.

Probably good long term buying if you believe in the sector and their NTA uplift from today +$12 and your patient..lol

Basil

#321
https://api.nzx.com/public/announcement/468297/attachment/463399/468297-463399.pdf

Very good result, as usual.  An extremely well managed company with a well proven track record of growth extending all the way back to when it first listed in late 2011.  Underlying profit was just $38m in 2015, now $234m.  10 year underlying EPS CAGR 18% !

I see underlying EPS of 95 cps for FY25  NTA 10 years ago was $1.89, now $13.75.  Embedded value of just on $8 per share.

Has been an outstanding performer ever since it listed.

I had a brief foray into SUM in 2025 in a very small way and got stopped out on a 10% stop loss limit I apply to all new positions.  Only lost a few thousand dollars.  Before that I sold out a decent sized holding at $9 in early 2020 just before Covid hit as a capital preservation measure.  Happy with that decision as my portfolio performance in the last 6 years has vastly outstripped the share price performance of SUM..

So with the above outstanding metrics and the company performing in a completely different league to its peers, 1. why is the share price going nowhere and has basically done a round trip to nowhere since I sold out 6 years ago and 2, why am I not a holder now ?

The first is a very difficult question to answer, the second is simple, this simply doesn't fit my investment parameters now in that being close to retirement I need a decent dividend yield with the vast majority of my portfolio.

Possibly answers to question 1 in my opinion in order of importance include:
a) The endless malaise the housing market is stuck in and the outlook appears to be for more of the same
b) Greatly increased competition in the sector from listed and unlisted companies making many parts of the retirement market over supplied
c) Their relatively slow start with their Australian growth plans and very modest development margin of 8-10% over there suggesting there's quite considerable work to be done on development efficiencies there
d) The popularity of this sector has been very badly tarnished by horrific value destruction by RYM over the last 10 years, (was $8.50 a decade ago), and endless lackluster performance from OCA
e) The pitiful unimputed dividend yield makes this extremely unattractive for retiree's who need income.
f) possible overhang of stock in this sector from a possible listing of MET.

Opportunity knocks for long term capital appreciation for younger investors.
The housing market will not stay in the doldrums forever but a protracted period of sideways type price movement (declining in real terms by 2-3% per annum), in my opinion should be expected.  The almost endless malaise of house prices could easily extend through the remainder of this decade and possibly even longer
For long term investors who don't need yield, I think SUM makes a compelling case to be included as part of a well diversified portfolio.  I don't see any reason at all to own anything else in this sector other than SUM for those investors.  Others in this sector have not earned and don't deserve the trust of investors in my opinion.  SUM have well and truly earned the respect of the investment community, its just that this sector is so badly out of favour with investors.


entrep

This weakness is wild. Have not seem SUM underperform other retirement shares or the index like this in several years.
AI-powered NZX announcement analysis → annolyse.ai

Gerald

Doesn't seem crazy relative to RYM (green), if anything the divergence between OCA and the rest is most noticeable.

Maybe investors have started to hear about the joys of the 'float' at OCA.

You cannot view this attachment.

Basil

#324
Market seems unhappy with SUM.  If I was a younger dog I'b be watching the chart closely looking for the bottom.

The yield on these does my head in.

HAWKDOG

Asked Claude what his theory on SUM's underperformance was and received this answer?

Good question! Here's a theory piecing together what we know about Summerset's situation right now.

Why SUM.NZX Is Lagging — A Working Theory

The short summary: Summerset's underlying business is actually performing well, but several macro and sector-specific headwinds are weighing heavily on the share price.

1. NZ Property Market Weakness
This is probably the biggest driver. Retirement village operators like Summerset are deeply tied to house prices — when residents move in, they often sell their family home first, and when they leave, the village recycles that unit value. Housing inventory is at a 10-year high, creating a buyer's market, and net migration has dropped off since its 2023 peak, removing a key source of demand. � A soft property market directly compresses the resale margins Summerset earns on its units. This showed up in results — while FY25 underlying profit was a record $234.2m (up 13%), IFRS net profit after tax was down to $259.7m, with the change largely driven by lower median house prices impacting revaluations of the company's portfolio. �

2. Interest Rate Uncertainty
OCR cuts through 2025 were supposed to be a tailwind, but the picture has become murkier. ANZ has cut its 2026 house price inflation forecast to 2% (from 5%), arguing that as the cycle progresses, mortgage rates may shift from a tailwind to a headwind if the OCR track turns less accommodative — with their first OCR hike expectation now brought forward to December 2026. � Markets hate uncertainty, and rising rate expectations tend to reprice property-linked stocks downward.

3. Share Price Already Reflects the Underperformance
SUM is down about 15% over the past 52 weeks on the NZX �, which is significant underperformance. As of mid-March 2026, shares were trading around $10.14, reflecting a 13.18% 52-week decline. � Yet analysts remain relatively bullish — the analyst consensus price target is around $14.04 NZD, with a max estimate of $16.00. � That gap between the current price and analyst targets suggests the market is pricing in risks that analysts may be underweighting.

4. Earnings Quality Concerns
Retirement village sector earnings can be hard to read. The headline IFRS profit swings based on property revaluations, which introduces volatility unrelated to operating performance. This can make investors nervous even when underlying profits are growing, as it adds noise to the earnings story.

5. Macro NZ Headwinds More Broadly
New Zealand has seen a continued exodus of residents to Australia — every family leaving is one fewer buyer and potentially one more seller — and unemployment concerns linger. � This weighs on consumer confidence, which affects the pace at which retirees commit to moving into a village.

The Contrarian Angle
With a P/E of around 9.4 and analysts sitting well above the current price, the case can be made that SUM is being over-punished by the market. If the NZ housing market stabilises and OCR fears ease, the stock could re-rate meaningfully. The demographic tailwind (ageing NZ population) is a genuine long-term driver that hasn't gone away.

As always, this is a theoretical analysis, not financial advice — I'm not a financial advisor. Worth speaking to one before making any investment decisions.
"The public loses interest just when opportunity returns."
— Stan Weinstein

Basil

#326
Excellent synopsis.  I think if I was a shareholder I would have significant concern about their very poor development margin of only 8% in Australia.

On one hand this is a relatively small part of their overall business, however on the other hand Australia offers a massive long term opportunity but yet, despite being there for many years they are not yet executing with anywhere near satisfactory margin. Why not ?

entrep

INVESTMENT MEMO: Summerset Group Holdings Limited (SUM.NZX)
Date: 23 March 2026
Current Price: NZ$9.32
NTA per Share: NZ$13.75 (31 Dec 2025)
Market Capitalisation: ~NZ$2.3 billion
Recommendation: Attractive for long-term, patient capital

EXECUTIVE SUMMARY
Summerset is the best-in-class retirement village developer and operator in New Zealand, now expanding into Australia. The company just delivered a record FY25 underlying profit of $234.2m (+13%) on record sales of 1,560 units (+26%), yet the share price has fallen ~25% from mid-2025 highs and trades at a 32% discount to NTA. The disconnect between operational excellence and share price creates an opportunity, though significant macro headwinds explain the de-rating and could persist.

The core thesis is simple: SUM is a proven compounder (NTA 6x growth since FY16, underlying EPS ~18% CAGR over 10 years) trading near multi-year lows because the entire NZ retirement village sector is deeply out of favour due to property market malaise, interest rate uncertainty, and sector contamination from the Ryman Healthcare debacle.

COMPANY OVERVIEW
Summerset builds, owns and operates integrated retirement villages across New Zealand (40 villages) and is expanding into Victoria, Australia (4 villages in development). The business serves 9,500+ residents with 7,198 retirement units and 1,475 care units in its existing portfolio, with a land bank of 6,672 additional units (NZ and Australia).

Business Model: Summerset generates returns through:

Development margin on first-time sale of new units under Occupation Right Agreements (ORAs) — 27.8% in FY25
Resale gains and DMF realisation when residents vacate and units are resold — $104.5m realised resale gain + $60.6m DMF in FY25
Ongoing village and care fees — growing as the portfolio matures
Interest-free resident loans — $3.3b of residents' capital funding the asset base

The company claims "no core debt" — arguing that development assets ($2.3b) exceed net debt ($1.96b) by $318m, and that the first sell-down of each village fully repays the capital invested.

FY25 FINANCIAL HIGHLIGHTS

Key observations:

The IFRS profit decline is driven by lower fair value movements of investment property ($264.5m vs $364.7m restated), reflecting the subdued NZ housing market. This is a non-cash, mark-to-market item.
Underlying profit — which strips out unrealised revaluations — grew 13%, demonstrating genuine operational momentum.
A prior period restatement of investment property values (relating to the accounting treatment of long-term resident loans) reduced FY24 investment property by $24.9m and FY23 by $17.1m. This is small (<0.5% of total) but is a minor governance mark.


VALUATION
At $9.32, SUM trades on the following metrics:
MetricValueP/Underlying Earnings~9.8x
Price/NTA0.68x (32% discount)
Price/Embedded Value (NTA + $1.9b embedded)~0.40x
Dividend Yield2.6% (unimputed)
EV/Underlying EBITDA~13.5x (est.)

Broker targets (most recent):

Forsyth Barr: $14.30 (OUTPERFORM, Nov 2025) — later trimmed to $11.70 post-1H25 annuity earnings weakness
Craigs Investment Partners: $16.63 (OUTPERFORM, Jul 2025)
Consensus mean: ~$14 (per forum discussion citing analyst data)

NTA trajectory: Management has disclosed that villages under construction are estimated to generate ~$12.00 per share of additional NTA uplift once complete and sold down. Of this, ~$2.50 has been delivered, leaving ~$9.50 to come. Combined with the current $13.75, this implies potential future NTA well above $20 per share over the medium term, subject to property market conditions.
The valuation case in a sentence: You are buying a proven growth compounder at <10x underlying earnings and a 32% discount to current NTA, with a pathway to NTA roughly doubling over the development cycle.

COMPETITIVE STRENGTHS — WHY SUM IS "BEST IN CLASS"

Unbroken execution track record: SUM has never missed a build delivery target since listing in 2011. FY25 delivered 693 units across NZ and Australia, consistent with guidance. This is remarkable in construction-intensive businesses.
Fully integrated, in-house development model: SUM is the only NZ-listed retirement operator that retains a complete internal development and construction capability. This provides cost control, quality assurance, and margin discipline (28% development margins vs 20-25% medium-term target).
Broadacre strategy with regional diversification: The focus on easily-stageable broadacre sites (typically ~10ha) across diverse NZ regions allows SUM to modulate build rates to match demand. Eight regions saw 40+ settlements each in FY25.
Lowest DMF in the sector at 25%: This is the most competitive offering for residents (competitors charge 30%+), supporting demand and brand strength. SUM is #1 in brand "consideration" and "first choice" among its target audience.
Largest land bank: 6,672 units in NZ and Australia, enabling the portfolio to nearly double over time.
Experienced, stable management: CEO Scott Scoullar (with SUM since 2014, previously CFO, protégé of founder Julian Cook) and Head of Construction Dean Tallentire provide deep institutional knowledge and proven execution capability.
Best-in-class resident satisfaction: 91% village satisfaction, 89% care satisfaction, 84% staff retention (up 3%).
Growing care ORA model: The conversion of care beds to ORA has materially improved care profitability — care EBITDA surged from $2.7m (FY24) to $18.8m (FY25), with further upside as more beds convert. DMF on care units increasing to 27.5% from 1 January 2026.
No equity raise required: Unlike peer Ryman Healthcare (which raised ~$1 billion in early 2025 and ~$1 billion prior), SUM has maintained its growth trajectory without dilutive capital raises.


GROWTH CATALYSTS
1. Australian Expansion

Four villages under construction in Victoria (Cranbourne North, Chirnside Park, Oakleigh South, Torquay) with three further proposed sites (Craigieburn, Drysdale, Mernda) plus a new planning permit lodged for Mornington.
Target 300 units per year in Australia from FY27.
Sales momentum building: 1.5+ contracts per week since Q4 2025, Chirnside Park 60% sold of first release.
Net cash position on Australian completion forecast around breakeven; expected to add >$550m NTA.
Development margins of 8-10% in Australia are lower than NZ (~28%), reflecting early-stage market entry. This is a watch item but expected to improve as SUM brings construction in-house (Torquay targeted as first internally-managed Australian build).
Queensland expansion being explored with a dedicated land targeting specialist.

2. Massive NTA Uplift in Pipeline

~$12 per share of NTA uplift from current developments (villages + care centres).
$240m+ of projected net cash profits from villages under construction.
Completed villages in FY25 (Bell Block, Te Awa) returned combined cash profit of $72.7m at $105k per unit average.

3. Care Bed Conversion to ORA

586 care beds identified for conversion (of 778 total targeted for ORA).
125 conversions completed in FY25 at $250k average, 23% margin.
Target: 75% of all care beds under ORA over time.
Medium-term target: care EBITDA per bed of $20-25k per annum (vs ~$13k in completed villages currently).

4. Improving NZ Housing Market (eventual)

SUM is the most operationally leveraged to any NZ housing recovery given its development capacity and the flexibility to scale up deliveries.
Affordability has returned to long-run average levels; falling interest rates should eventually be supportive.
Q1 2026 sales ahead of FY25 same period per company guidance.

5. Competitive Consolidation

NZ retirement village consents at lowest level in a decade.
Key competitor Ryman has radically reduced its development book.
Oceania Healthcare and Arvida have struggled operationally.
SUM is positioned to gain significant market share.


KEY RISKS AND CONCERNS
1. NZ Property Market Malaise (HIGH)
This is the single biggest headwind. NZ house prices have been declining in real terms for ~5 years. The forum discussions extensively debate this, with one knowledgeable poster ("Basil") arguing that real inflation-adjusted house prices are down ~30% from the late 2021 peak and could remain flat to declining for years. Key indicators:

Housing inventory at 10-year highs
Net migration has dropped sharply from 2023 peak
ANZ has cut 2026 house price inflation forecast to just 2%
Interest rate path uncertain — the anticipated OCR cutting cycle has become murkier, with some forecasters now expecting rate hikes by late 2026

This matters because: (a) resale margins compress when house prices are flat/falling (residents can't sell homes quickly or for as much); (b) fair value movements on investment property decline, reducing IFRS profits; (c) prospective residents delay purchasing decisions.
However, SUM has demonstrated resilience: FY25 was another record sales year despite these conditions, and underlying profit grew 13%. The business model has proven more robust to property cycles than pure housing developers.
2. Balance Sheet / Net Debt ($1.96 billion) (MEDIUM-HIGH)
Net debt has roughly tripled since FY20 ($680m). While management guides for the $2.0-2.5b band and gearing to decline in FY26, the quantum is substantial:

Gearing of 37.1% is within the 30-40% target but above the historical range
LVR covenant at 38.5% vs 50% limit — reasonable headroom but not massive
Interest cover at 6.43x is strong
$626.8m undrawn facility provides buffer

Forsyth Barr noted (Aug 2025) that cash conversion of sales was the worst on record and net debt came in higher than expected. Management has guided for flat to declining net debt from here, which would be a material positive inflection if achieved.
There is no indication of a capital raise need. The company has explicitly denied it. Development assets exceed net debt by $318m.
3. Australian Execution Risk (MEDIUM)

Only 8-10% development margins in Australia vs 28% in NZ
Very early stage — only 98 units in total Australian portfolio
Operational complexity of entering a new market with different regulatory, care and consumer dynamics
The new Australian Aged Care Act (effective 1 Nov 2025) adds regulatory uncertainty
Working toward bringing construction in-house to improve margins — not yet proven in Australia

Australia is a very large addressable market and could be transformative, but the returns need to improve materially for this to be value-accretive rather than a capital sink.
4. Property Revaluation Dependency (MEDIUM)
One forum poster (KW) correctly noted that FY25 IFRS profit was substantially supported by $264.5m of property revaluations — including $123m from a revaluation uplift (of which $54.8m was reversal of valuers' stock discount assumptions). If the property market deteriorates further, these could reverse, pressuring IFRS earnings and potentially NTA.
That said, underlying profit (the metric used for dividends and internal management) strips out revaluations and grew 13%.
5. Cash Flow Generation from Existing Operations (MEDIUM)
Cash flow from existing operations (CFEO) was just $32.3m in FY25 on a $9.2 billion asset base. Villages at the "operating" level (excluding development) lose money on a cash basis — village and care fees of $220m are exceeded by village suppliers and employees of $238.4m. This is offset by resale cash flows of $145.4m and care bed conversion receipts.
The "Ponzi" concern raised in the forums is overstated but not entirely without merit — the business model requires ongoing development to generate development margins, and existing village cash yields are modest (5.3% in mature villages, 1.1% overall including corporate). Management's task is to demonstrate that as the portfolio matures and care ORA conversions embed, CFEO improves materially.
6. Sector Sentiment / Metlife Care Re-listing Overhang (MEDIUM)
The entire NZ retirement sector is deeply out of favour. All listed operators are down 12-14% YTD. A potential re-listing of Metlife Care could create additional supply of retirement sector equity. Fund managers may be selling existing RV holdings to accommodate new listings.
7. Low Dividend Yield (LOW-MEDIUM for income investors)
The 2.6% unimputed dividend yield is unattractive for income-focused investors. The 20-50% payout range on underlying profit suggests dividends will grow with earnings but will remain modest relative to yield alternatives.
8. Regulatory Risk — Aged Care Funding (LOW-MEDIUM)
SUM has flagged it may restrict care centres to village residents only due to government underfunding of aged care. While this is a rational economic response, it has reputational and potential regulatory implications.

COMPARISON WITH SECTOR PEERS
SUM is unquestionably the sector leader. The forum discussions are emphatic and data-supported on this point:
SUM trades at a premium to peers on P/NTA, which is appropriate given the quality differential. However, the absolute valuation at <10x underlying PE is undemanding by historical standards.

FINANCIAL PROJECTIONS (SIMPLIFIED)

Based on Craigs' July 2025 estimates ($1.00, $1.07, $1.16 EPS), Forsyth Barr's +13% annuity earnings growth in FY26-27, and current sales momentum. These assume relatively stable NZ property market and continued Australian ramp.
At $9.32, implied FY26 PE: ~9x. FY27 PE: ~8-8.6x.

WHAT COULD GO WRONG (BEAR CASE)

NZ house prices fall a further 10-15% in real terms, compressing resale margins and requiring investment property write-downs that erode NTA
Interest rates rise rather than fall, pushing gearing toward the top of the range
Australian development proves to be a capital-destroying exercise with margins stuck at 8-10%
A Metlife Care re-listing depresses sector multiples further
Government regulatory intervention on the ORA/DMF model
In a deep bear case, NTA could decline and the discount could widen, producing capital losses even from current depressed levels

Downside scenario: If NTA declined to ~$12 and the stock traded at 0.6x NTA, the share price could fall to ~$7.20 (a further -23%).

WHAT COULD GO RIGHT (BULL CASE)

NZ housing market stabilises and begins recovering, driving IFRS earnings recovery and NTA expansion
Australian villages hit their stride with margins improving toward 15%+
Care ORA conversions drive care EBITDA to $40-50m (from $18.8m)
Sector re-rating as investors recognise the disconnection between operating performance and valuations
Net debt peaks and declines, removing a key investor concern
Competitor weakness (Ryman, Oceania) allows SUM to capture disproportionate demand

Upside scenario: If the P/NTA discount narrows to 0.9x and NTA reaches $18-20 over 3 years, the stock could reach $16-18 (70-90% upside). Craigs' mid-2025 target of $16.63 is illustrative of this scenario.

CONCLUSION
Summerset is an exceptional operator trading at a valuation that assumes the worst. At $9.32:

You pay <10x record underlying earnings for a company with a 10-year underlying EPS CAGR of ~18%
You get a 32% discount to current NTA of $13.75, with $9.50 per share of NTA still to be created from existing developments
You get the best management team in the NZ retirement sector with an unblemished delivery record
You get an early-stage Australian growth optionality that could be transformative

The risks are real: NZ property malaise, elevated debt, Australian execution uncertainty, and deep sector pessimism. The share price could remain depressed or fall further if the housing market deteriorates.
But the asymmetry is compelling. Even modest improvement in conditions could drive a significant re-rating. A return to 1.0x NTA (let alone any premium) on current NTA implies $13.75 — 47% upside. If NTA grows as guided, the upside is substantially greater.
For long-term investors who can tolerate near-term volatility and don't require yield, SUM at $9.32 represents one of the more compelling risk-reward propositions on the NZX. This is a genuine quality-at-a-discount opportunity, with the caveat that the catalysts for re-rating (housing recovery, debt peak, Australian proof points) may take 12-24 months to materialise.
Position sizing should reflect the macro uncertainty — this is not a table-pounding "all-in" at current prices given the property market headwinds, but a strong candidate for a meaningful portfolio position built over time.
AI-powered NZX announcement analysis → annolyse.ai

Basil

Crickey A.I. is getting very good.  Don't think I could have said it better if I took quite a few hours to draft it up.

theBusinessman

Is it tempting you yet, Basil?
Disc: not a holder but I've been taking notice...